These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Modulation of light-induced C-Fos expression in the suprachiasmatic nuclei by 5-HT1A receptor agonists. Glass JD, Selim M, Rea MA. Brain Res; 1994 Feb 28; 638(1-2):235-42. PubMed ID: 8199864 [Abstract] [Full Text] [Related]
7. Involvement of the retinohypothalamic tract in the photic-like effects of the serotonin agonist quipazine in the rat. Graff C, Kohler M, Pévet P, Wollnik F. Neuroscience; 2005 Feb 28; 135(1):273-83. PubMed ID: 16084651 [Abstract] [Full Text] [Related]
8. Dark pulse suppression of P-ERK and c-Fos in the hamster suprachiasmatic nuclei. Coogan AN, Piggins HD. Eur J Neurosci; 2005 Jul 28; 22(1):158-68. PubMed ID: 16029205 [Abstract] [Full Text] [Related]
11. Local effects of the serotonin agonist quipazine on the suprachiasmatic nucleus of rats. Kalkowski A, Wollnik F. Neuroreport; 1999 Oct 19; 10(15):3241-6. PubMed ID: 10574568 [Abstract] [Full Text] [Related]
14. A cholinergic antagonist, mecamylamine, blocks light-induced fos immunoreactivity in specific regions of the hamster suprachiasmatic nucleus. Zhang Y, Zee PC, Kirby JD, Takahashi JS, Turek FW. Brain Res; 1993 Jun 25; 615(1):107-12. PubMed ID: 8364719 [Abstract] [Full Text] [Related]